Chugai Seiyaku Kabushiki Kaisha

Sumitomo Chemical Company, Limited

Other

Agc Inc.

Doryokuro Kakunenryo Kaihatsu Jigyodan

Raax Co., Ltd.

Taisei Kiso Sekkei Co., Ltd.

Masahiko Tamura

Takeshi Kawasato

Tatsuya Miyai

Yasuhiro Oda

Keiichi Fukuda

Ryo Eguchi

Yasuyo Hisaka

Satoshi Asakura

Yoichi Hirata

Kazuyuki Goto

Koichi Yanagisawa

Shunichi Kamewada

Tomoo Kato

Katsushi Nakano

Takuma Nara

Satoshi Yamana

A glass substrate for EUVL includes a first main surface having a rectangular shape; a second main surface having a rectangular shape on an opposite side to the first main surface; four end surfaces orthogonal to the first and second main surfaces; four first chamfered surfaces formed on boundaries between the first main surface and the end surfaces; and four second chamfered surfaces formed on boundaries between the second main surface and the end surfaces. The glass substrate for EUVL is formed of quartz glass containing TiO. The end surfaces include fluorine (F) and an element (A) other than fluorine that forms a gas cluster with fluorine, and satisfy relations:

Glass substrate for EUVL, manufacturing method thereof, mask blank for EUVL, and manufacturing method thereof

There is provided a production method of a lithium-containing composite oxide capable of improving performances of cycle characteristics, rate characteristics, and the like of a lithium ion secondary battery. A production method of a lithium-containing composite oxide is characterized in that when producing a lithium-containing composite oxide by mixing a transition metal hydroxide containing Ni and Mn essentially and a lithium source and heating the mixture, a transition metal hydroxide having a crystallite diameter of the (100) plane being 35 nm or less in a crystal structure model in the space group P-3m1 of an X-ray diffraction pattern is used.

Production method of lithium-containing composite oxide and lithium-containing composite oxide

To provide a lithium-containing composite oxide, a cathode active material and a positive electrode for a lithium ion secondary battery, with which a lithium ion secondary battery having favorable cycle characteristics even when charged at a high voltage can be obtained; and a lithium ion secondary battery having favorable cycle characteristics even when charged at a high voltage. A lithium-containing composite oxide which is represented by LiNiCoMnMOwherein M is Mg, Ca, Al, Ti, V, Nb, Mo, W or Zr, a+b+c+d+e=2, 'a' is from 1.01 to 1.10, b is from 0.30 to 0.95, c is from 0 to 0.35, d is from 0 to 0.35, and e is from 0 to 0.05, wherein in an X-ray diffraction pattern obtained by reflection X-ray diffraction employing Cu-K&#x3b1; rays, the ratio (I/I) of the integrated intensity (I) of a peak of (104) plane to the integrated intensity (I) of a peak of (110) plane is at least 4.20.

Lithium-containing composite oxide, cathode active material, positive electrode for lithium ion secondary battery, and lithium ion secondary battery

A lithium-containing composite oxide essentially containing Li, Ni, Co and Mn, which has a crystal structure with space group R-3m, with a c-axis lattice constant being from 14.208 to 14.228 &#x212b;, and with an a-axis lattice constant and the c-axis lattice constant satisfying the relation of 3a+5.615&#x2264;c&#x2264;3a+5.655, and of which the integrated intensity ratio (I/I) of the (003) peak to the (104) peak in an XRD pattern is from 1.21 to 1.39.

Lithium-containing composite oxide and process for its production

An effective agent for treating ischemic disease, the agent containing human granulocyte colony-stimulating factor (human G-CSF) as an active ingredient is disclosed. By administering this therapeutic agent, an effective therapy particularly for obstructive arteriosclerosis is provided which can eliminate drawbacks with conventional therapies, such as kinesitherapy, pharmacotherapy, and revascularization, and recently proposed therapies, such as gene therapy and intramuscular transplantation of bone marrow cells. Furthermore, the therapeutic agent can be used as an agent for treating ischemic disease, such as ischemic cerebrovascular disorder or ischemic heart disease.

Remedies for ischemic disease of the limbs comprising administration of G-CSF

An effective remedy for ischemic disease, which contains human granulocyte colony-stimulating factor (human G-CSF) and hepatocyte growth factor (HGF) as active ingredients, is disclosed. By administering this remedy, an effective therapy particularly for obstructive arteriosclerosis is provided which can eliminate drawbacks with conventional therapies such as kinesitherapy, pharmacotherapy, revascularization and recently proposed therapies such as gene therapy and intramuscular inoculation of bone marrow cells. Furthermore, the remedy of the present invention can become a remedy for ischemic disease such as ischemic cerebrovascular disorder or ischemic heart disease.

Remedies for ischemic disease

Method of increasing blood platelet formation by administering a parathyroid hormone (PTH) or at least one PTH derivative as an active ingredient.

Agents for preventing and treating thrombocytopenia

Agents for preventing and treating thrombocytopenia, thrombocytopenic purpura and various diseases that tend to cause bleeding due, presumably, to thrombocytopenia contain a parathyroid hormone (PTH) or at least one PTH derivative as an active ingredient.

Remedies for thrombocytopenia

The present invention provides a hydraulic test system, by which it is possible to select a proper position and to select a reliable measurement interval corresponding to said position, to obtain information for preventing retention or leaving of the equipment in the borehole, and to observe the conditions in front and lateral directions by a single BTV at the same time and at wide angle of view without adjusting focal point. On the tip of a measurement pipe to be inserted into a borehole, a waterproofing cylinder with a transparent window oriented for simultaneously observing in both the front and lateral directions is mounted, and there are provided illumination units for illuminating in front direction and side walls and a borehole television set equipped with a ball lens, spherical mirror lens or matched convex pair of lens system in said cylinder, which forms a virtual image of an object in front direction and a reflected virtual image of an object in lateral direction on almost the same plane.

Growing community of inventors

Tokyo, Japan

Masahiko Tamura